Kestra Medical Technologies Inc 与 Biobeat 达成协议 含独家许可及对B轮融资500万美元股权投资

美股速递
Jan 13

Kestra Medical Technologies Inc 宣布与 Biobeat 签署一项重要合作协议。该协议的核心条款包括获得一项独家技术许可授权,以及 Kestra 将对 Biobeat 的 B 轮融资进行一笔价值 500 万美元的股权投资。

此项合作标志着 Kestra 在拓展其医疗技术版图方面迈出了关键一步。独家许可协议将增强 Kestra 的产品组合和技术实力,而股权投资则体现了其对 Biobeat 未来发展潜力的坚定信心。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10